Dallas, March 03, 2022 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global pharmacogenomics (PGx) market is expected to grow from USD 6.73 billion in 2020 to USD 11.63 ...
The PGX ETF provides exposure to an index of fixed-rate preferred shares. PGX pays a generous 5.8% trailing distribution yield. Historically, PGX total returns are primarily driven by interest rates ...
Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...
In trading on Thursday, shares of the Invesco Preferred ETF (Symbol: PGX) entered into oversold territory, changing hands as low as $11.19 per share. We define oversold territory using the Relative ...
PGX offers diversified exposure to preferred securities, with 80% in fixed-rate instruments and a moderate risk profile focused on the financial sector. The fund's average credit rating is BBB, and it ...
KENILWORTH, N.J.--(BUSINESS WIRE)--With adverse drug events (ADEs) triggering an estimated 700,000 ED visits and 120,000 hospitalizations, RDx BioScience (RDx) points ...
Income-minded investors who are looking for ways to enhance their yield generation in a lower-for-longer rate environment can consider preferreds-related exchange traded funds for more attractive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results